- NATURE INDEX
Although the field’s breakthrough research has the potential to save lives, it requires a more in-depth and equitable foundation of research.

Credit: Peter Greenwood/Folio
In the past three decades, the field of regenerative medicine has advanced rapidly, driven by breakthroughs in areas such as cell therapy, in which specific cell types are transferred into a patient to treat or prevent disease, and tissue engineering, which uses various methods to grow or repair damaged human tissues.

Nature Index 2026 Regenerative medicine
Induced pluripotent stem cells (iPSCs), which can be turned into any cell type in the body, are being used to develop potential treatments for conditions such as autoimmune diseases, Parkinson’s disease and heart failure. As highlighted in a feature article, clinical trials using stem-cell transplants to replace the insulin-producing cells that are missing in people with type 1 diabetes have had some success.
Nature 657, S51 (2026)
doi: https://doi.org/10.1038/d41586-026-02854-1
This article is part of Nature Index 2026 Regenerative medicine, an editorially independent supplement. Advertisers have no influence over the content. For more information about Nature Index, see the homepage.
Related Articles
-
‘Remarkably encouraging’: stem-cell treatments for autoimmune diseases enter new phase
-
Competition heats up in the regenerative-medicine ranks
-
Lack of female researchers and participants in regenerative-medicine research holds everyone back
-
Partner content: Exploring the potential of regenerative medicine
-
Partner content: Regenerative promise for complex medical conditions
-
Partner content: A clear path to determining stem cell readiness
-
Partner content: A pathway to improve the health of joints
-
Partner content: A regenerative approach for treating diabetes?
-
Partner content: A two-pronged way to advance regenerative medicine tools
-
Partner content: Engineering a better approach to regenerative medicine
-
Partner content: Building the foundations for next-generation cell therapies
-
Partner content: What regenerative medicine could learn from LNG plants
-
Partner content: Building the infrastructure for cellular therapies
-
Partner content: How to produce living medicine at scale
-
Partner content: Regenerative hope for musculoskeletal disorders
-
Partner content: Can stem cells help turn back the clock?
-
Partner content: How to bridge capability gaps in drug R&D
-
Partner content: Collective thinking helps accelerate impact in regenerative medicine
-
Partner content: Regenerative medicine is moving from discovery to delivery
Subjects
Latest on:
- Medical research
- Regeneration
- Cell biology
-
Competition heats up in the regenerative-medicine ranks
Nature Index
-
Lack of female researchers and participants in regenerative-medicine research holds everyone back
Nature Index
-
‘Remarkably encouraging’: stem-cell treatments for autoimmune diseases enter new phase
Nature Index
-
ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer
Article
-
Gene therapies to fix failing hearts gain steam after years in the doldrums
News
-
This organoid can menstruate — and shows how tissue can repair itself
News
-
All the ways a cell can die — and why the variety matters
News Feature
-
These bizarre, much-coveted microbes are revealing the origins of complex life
News Feature
-
Mitochondrial fission factor senses and governs ferroptosis
Article